skip to content

The Elliott Group

 

Head injury is the leading cause of death in the under 40 years old. In neurocritical care, brain chemistry can be monitored by inserting fine semi-permeable catheters into the brain. The commercially-available bedside analyser cannot measure brain chemistry continuously, is expensive to purchase and maintain, and labour-intensive. Thus, rapid changes in brain chemistry cannot be monitored currently. We are developing an online sensor technology for use in neurocritical care of acute brain injury patients.

Project collaborators: Prof Peter Hutchinson, Dr Keri Carpenter and Dr Susan Van der Heide Division of Neurosurgery, Dept. of Clinical Neurosciences, University of Cambridge

The research is funded by theĀ National Institute for Health Research (NIHR) Brain Injury Healthcare Technology Co-operativeĀ (https://brainhtc.org) based at Cambridge University Hospitals NHS Foundation Trust and University of Cambridge.